Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
385M
-
Number of holders
-
722
-
Total 13F shares, excl. options
-
277M
-
Shares change
-
+15.9M
-
Total reported value, excl. options
-
$11.5B
-
Value change
-
+$499M
-
Put/Call ratio
-
1.27
-
Number of buys
-
297
-
Number of sells
-
-409
-
Price
-
$41.58
Significant Holders of Moderna, Inc. - COMMON STOCK (MRNA) as of Q4 2024
985 filings reported holding MRNA - Moderna, Inc. - COMMON STOCK as of Q4 2024.
Moderna, Inc. - COMMON STOCK (MRNA) has 722 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 277M shares
of 385M outstanding shares and own 71.92% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (40.3M shares), BAILLIE GIFFORD & CO (38.9M shares), BlackRock, Inc. (25.8M shares), FMR LLC (18.7M shares), STATE STREET CORP (17.6M shares), Theleme Partners LLP (7.31M shares), GEODE CAPITAL MANAGEMENT, LLC (7.24M shares), UBS Group AG (5.07M shares), Invesco Ltd. (5.01M shares), and Flagship Pioneering Inc. (4.63M shares).
This table shows the top 722 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.